Eindhoven-based health tech startup Salvia BioElectronics has raised €53 million in a Series B round to accelerate the clinical and commercial rollout of its migraine treatment technology.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?